Markets Gone Wild

Findings show which age groups are seeing the biggest increases ATLANTA , Oct. 29, 2024 /PRNewswire/ — LexisNexis® Risk Solutions, a leading provider of data and analytics, released new insights on breast and colon cancer screening and diagnosis trends from 2021 to 2023. As the U.S. Preventive Services Special Task Force (USPSTF) continues to examine…

Revolutionizing SMA Treatment: The DEVOTE Study The Potential of Nusinersen’s Higher Dose Regimen Have you heard the buzz about the latest breakthrough in treating Spinal Muscular Atrophy (SMA)? Applications are now being developed based on data from the DEVOTE study, which reveal the exciting potential of an investigational higher dose regimen of nusinersen. For those…

SCIENTURE HOLDINGS’ ANNOUNCEMENT: On March 19, 2025, SCIENTURE HOLDINGS, Inc. (SCNX), a leading pharmaceutical holding company, made two significant announcements: Completion of Equity Line of Credit (ELOC) Draw The first announcement was regarding the completion of a draw on its Equity Line of Credit (ELOC) to support the commercial launch of Arbli™ (losartan potassium) Oral…

Unlocking the Future of Visa: A Look into the Market Performance and Growth Opportunities Understanding Visa’s Market Performance Over the past five years, Visa has faced challenges in the market, underperforming by nearly 20 points. This can be attributed to multiple contractions, despite strong growth in its earnings per share (EPS). However, the company is…

Understanding the Elastic N.V. (ESTC) Lawsuit: Your Rights and Potential Recovery If you have recently experienced financial losses after investing in Elastic N.V. (ESTC), you may be wondering about your legal options under the federal securities laws. In this article, we will discuss the details of the ongoing lawsuit against Elastic N.V., your potential eligibility…